Completion of this licensing agreement transferring copyright ownership to Formulary, is required and has to be signed by all article coauthors (a separate form for each author/coauthor of a single manuscript, each showing an original signature is required). The copyright form must not include any written notations other than the original written and printed signature of the author and date. This form should be mailed [not emailed or faxed] to Formulary when the article is submitted for publication consideration.
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More